- improved acrolein-induced cognitive impairment- protected acrolein-induced GSH deletion in both cortex and hippocampus- improved acrolein-induced SOD activity decline in the hippocampus - positively regulated AD-associated proteins. Here, SOD1 is linked to Alzheimer disease.